| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Department of Biomedical Science, Division of Experimental Pathology and Oncology, University of Sassari, I-07100 Sassari, Italy [M. R. D.M., R. M. P., M. M. S., M. R. M., D. C., F. F.], and Unit of Genetic Cancer Susceptibility, International Agency for Research on Cancer, Lyon F-69372 cedex 08, France [F. C., G. R.]
Neoplastic liver nodules and hepatocellular carcinomas (HCCs) were induced, by "resistant hepatocyte" model, 32 and 70 weeks after initiation with diethylnitrosamine, respectively, in F344 Brown Norway (BN), and (BNxF344)Fl rats. Nodule number/liver (N) did not significantly differ among rat strains, whereas nodule mean volume (V) and nodule volume fraction (VF) were higher in susceptible F344 than in resistant BN and BFF1 strains and were predictive of subsequent development of HCCs. Genomic scanning of 157 backcross BFFlxF344 rats with 190 polymorphic microsatellites, and linkage analysis, revealed two quantitative trait loci (QTL) on chromosomes 7 and 10, which showed significant linkage with VF, and two QTL on chromosomes 4 and 8, which showed suggestive linkage with V and VF. On the basis of phenotypic patterns of homozygous and heterozygous backcross progeny and of allelic distribution pattern, QTL on chromosomes 10, 8, and 4 were tentatively identified as resistance loci, and QTL on chromosome 7 was identified as susceptibility locus for rat hepatocarcinogenesis. An analysis of interactions allowed us to identify additional putative QTL on chromosomes 5 and 8 and suggested an additive effect of loci on chromosomes 10, 8, and 4 for VF and V. These data are the first to identify chromosomal regions containing putative susceptibility/resistance loci for rat hepatocarcinogenesis, which seems to be highly complex in terms of the number of genetic factors involved.
This article has been cited by other articles:
![]() |
F. Feo, M. Frau, M. L. Tomasi, S. Brozzetti, and R. M. Pascale Genetic and Epigenetic Control of Molecular Alterations in Hepatocellular Carcinoma Experimental Biology and Medicine, July 1, 2009; 234(7): 726 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Dragani 10 Years of Mouse Cancer Modifier Loci: Human Relevance Cancer Res., June 15, 2003; 63(12): 3011 - 3018. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.S. Falvella, R. M. Pascale, M. Gariboldi, G. Manenti, M. R. De Miglio, M. M. Simile, T. A. Dragani, and F. Feo Stearoyl-CoA desaturase 1 (Scd1) gene overexpression is associated with genetic predisposition to hepatocarcinogenesis in mice and rats Carcinogenesis, November 1, 2002; 23(11): 1933 - 1936. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. De Miglio, R. M. Pascale, M. M. Simile, M. R. Muroni, D. F. Calvisi, P. Virdis, G. M. Bosinco, M. Frau, M. A. Seddaiu, S. Ladu, et al. Chromosome Mapping of Multiple Loci Affecting the Genetic Predisposition to Rat Liver Carcinogenesis Cancer Res., August 1, 2002; 62(15): 4459 - 4463. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Wood, J. E. Korkola, and M. C. Archer Tissue-specific resistance to cancer development in the rat: phenotypes of tumor-modifier genes Carcinogenesis, January 1, 2002; 23(1): 1 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yan, Z.-Z. Zeng, S. Higashi, A. Denda, Y. Konishi, S. Onishi, H. Ueno, K. Higashi, and H. Hiai Resistance of DRH strain rats to chemical carcinogenesis of liver: genetic analysis of later progression stage Carcinogenesis, January 1, 2002; 23(1): 189 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Wood, D. S.R. Sarma, and M. C. Archer Inheritance of Resistance to Promotion of Preneoplastic Liver Lesions in Copenhagen Rats Experimental Biology and Medicine, October 1, 2001; 226(9): 831 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Z. Zeng, S. Higashi, W. Kitayama, A. Denda, Y. Yan, K. Matsuo, Y. Konishi, H. Hiai, and K. Higashi Genetic Resistance to Chemical Carcinogen-induced Preneoplastic Hepatic Lesions in DRH Strain Rats Cancer Res., June 1, 2000; 60(11): 2876 - 2881. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |